Healthcare Worker Exposure Response & Outcomes of Hydroxychloroquine Trial (HERO-HCQ)

PI(s): Mark Pelcher, University of California San Francisco; Madalaine Faulkner, University of California San Francisco; Rhonda Cooper-DeHoff, University of Florida

Project Summary: The purpose of this study is to evaluate the efficacy of hydroxychloroquine (HCQ) to prevent COVID-19 clinical infection in healthcare workers (HCWs) as well as to evaluate the efficacy of HCQ to prevent viral shedding of SARS-CoV-2 among HCWs and the safety and tolerability of HCQ.

Study Design: Multi-CRN Interventional Studies

PaTH Partners:

  • Johns Hopkins University (Harold Lehman, Site PI)
  • Penn State University (Cynthia Chuang, Site PI)
  • University of Pittsburgh (Kathleen McTigue, Site PI)

Coordinating Centers: University of California San Francisco and University of Florida

Twitter Logo
PaTH Network Logo
Twitter Logo Facebook Logo YouTube Logo

Copyright 2016 | PaTH Network